Safe utilization of ibrutinib with or without steroids in chronic lymphocytic leukemia patients with autoimmune hemolytic anemia.
Department of Medicine, Division of Hematology, London Health Sciences Centre, Room E6-219A, Victoria Hospital, 800 Commissioners Road East, London, Ontario, Canada, N6A 4G5.
Rosanne
R
St Bernard
Department of Medicine, Division of Hematology, London Health Sciences Centre, Room E6-219A, Victoria Hospital, 800 Commissioners Road East, London, Ontario, Canada, N6A 4G5. chsia@uwo.ca.
Cyrus C
CC
Hsia
D000744:Anemia, Hemolytic, Autoimmune / Q000139:chemically induced / Q000188:drug therapy*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy; D008297:Male; D008875:Middle Aged
D000893:Anti-Inflammatory Agents